Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Association between dietary flavonoids intake and prostate cancer risk: A case-control study in Sicily.

Reale G, Russo GI, Di Mauro M, Regis F, Campisi D, Giudice AL, Marranzano M, Ragusa R, Castelli T, Cimino S, Morgia G.

Complement Ther Med. 2018 Aug;39:14-18. doi: 10.1016/j.ctim.2018.05.002. Epub 2018 May 15.

PMID:
30012385
2.

Transurethral resection of the prostate (TURP) vs GreenLight photoselective vaporization of benign prostatic hyperplasia: analysis of BPH6 outcomes after 1 year of follow-up.

Cimino S, Voce S, Palmieri F, Favilla V, Castelli T, Privitera S, Giardina R, Reale G, Russo GI, Morgia G.

Int J Impot Res. 2017 Nov;29(6):240-243. doi: 10.1038/ijir.2017.30. Epub 2017 Aug 17.

PMID:
28814812
3.

A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of Curcumina and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III.

Morgia G, Russo GI, Urzì D, Privitera S, Castelli T, Favilla V, Cimino S.

Arch Ital Urol Androl. 2017 Jun 30;89(2):110-113. doi: 10.4081/aiua.2017.2.110.

4.

Comparison between Briganti, Partin and MSKCC tools in predicting positive lymph nodes in prostate cancer: a systematic review and meta-analysis.

Cimino S, Reale G, Castelli T, Favilla V, Giardina R, Russo GI, Privitera S, Morgia G.

Scand J Urol. 2017 Oct;51(5):345-350. doi: 10.1080/21681805.2017.1332680. Epub 2017 Jun 23. Review.

PMID:
28644701
5.

A Systematic Review and Meta-analysis of the Diagnostic Accuracy of Prostate Health Index and 4-Kallikrein Panel Score in Predicting Overall and High-grade Prostate Cancer.

Russo GI, Regis F, Castelli T, Favilla V, Privitera S, Giardina R, Cimino S, Morgia G.

Clin Genitourin Cancer. 2017 Aug;15(4):429-439.e1. doi: 10.1016/j.clgc.2016.12.022. Epub 2016 Dec 30. Review.

PMID:
28111174
6.

Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?

Russo GI, Cimino S, Castelli T, Favilla V, Gacci M, Carini M, Condorelli RA, La Vignera S, Calogero AE, Motta F, Puzzo L, Caltabiano R, Morgia G.

Prostate. 2016 Dec;76(16):1528-1535. doi: 10.1002/pros.23237. Epub 2016 Jul 25.

PMID:
27458062
7.

Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study.

Favilla V, Castelli T, Urzì D, Reale G, Privitera S, Salici A, Russo GI, Cimino S, Morgia G.

Int Braz J Urol. 2016 Jul-Aug;42(4):685-93. doi: 10.1590/S1677-5538.IBJU.2015.0243.

8.

Impact of combination therapy 5-alpha reductase inhibitors (5-ARI) plus alpha-blockers (AB) on erectile dysfunction and decrease of libido in patients with LUTS/BPH: a systematic review with meta-analysis.

Favilla V, Russo GI, Privitera S, Castelli T, Giardina R, Calogero AE, Condorelli RA, La Vignera S, Cimino S, Morgia G.

Aging Male. 2016 Sep;19(3):175-181. Epub 2016 Jun 16. Review.

PMID:
27310433
9.

Metabolic syndrome and prostatic disease: potentially role of polyphenols in preventive strategies. A review.

Castelli T, Russo GI, Reale G, Privitera S, Chisari M, Fragalà E, Favilla V, Cimino S, Morgia G.

Int Braz J Urol. 2016 May-Jun;42(3):422-30. doi: 10.1590/S1677-5538.IBJU.2015.0095. Review.

10.

Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction.

Fragalà E, Russo GI, Di Rosa A, Giardina R, Privitera S, Favilla V, Patti F, Welk B, Cimino S, Castelli T, Morgia G.

Int Neurourol J. 2015 Dec;19(4):272-7. doi: 10.5213/inj.2015.19.4.272. Epub 2015 Dec 28.

11.

Heme oxygenase levels and metaflammation in benign prostatic hyperplasia patients.

Russo GI, Vanella L, Castelli T, Cimino S, Reale G, Urzì D, Li Volti G, Gacci M, Carini M, Motta F, Caltabiano R, Puzzo L, Sorrenti V, Morgia G.

World J Urol. 2016 Aug;34(8):1183-92. doi: 10.1007/s00345-015-1736-8. Epub 2015 Nov 30.

PMID:
26621207
12.

Association between long-term erectile dysfunction and biochemical recurrence after permanent seed I(125) implant brachytherapy for prostate cancer. A longitudinal study of a single-institution.

Morgia G, Castelli T, Privitera S, Al-Nakib C, Favilla V, Marchese F, Cimino S, Russo GI.

Aging Male. 2016;19(1):15-9. doi: 10.3109/13685538.2015.1083546. Epub 2015 Sep 16.

PMID:
26376010
13.

Accuracy capabilities comparisons between Karakiewicz, Kattan and Cindolo nomograms in predicting outcomes for renal cancer carcinoma: A systematic review and meta-analysis.

Russo GI, Di Rosa A, Favilla V, Fragalà E, Castelli T, Privitera S, Cimino S, Morgia G.

Can Urol Assoc J. 2015 May-Jun;9(5-6):E359-66. doi: 10.5489/cuaj.2479.

14.

Predicting erectile dysfunction in sexually active patients seeking prostate health screening: proposal for a multivariable risk stratification.

Favilla V, Russo GI, Reale G, Leone S, Castelli T, La Vignera S, Condorelli RA, Calogero AE, Cimino S, Morgia G.

Int J Impot Res. 2015 Nov-Dec;27(6):201-5. doi: 10.1038/ijir.2015.15. Epub 2015 Jul 30.

PMID:
26224573
15.

Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review.

Russo GI, Castelli T, Urzì D, Privitera S, La Vignera S, Condorelli RA, Calogero AE, Favilla V, Cimino S, Morgia G.

Int J Urol. 2015 Nov;22(11):982-90. doi: 10.1111/iju.12877. Epub 2015 Jul 20. Review.

16.

Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis.

Russo GI, Castelli T, Urzì D, Privitera S, Fragalà E, La Vignera S, Condorelli RA, Calogero AE, Favilla V, Cimino S, Morgia G.

Aging Male. 2015;18(4):207-16. doi: 10.3109/13685538.2015.1062980. Epub 2015 Jul 14. Review.

PMID:
26171768
17.

Performance of biopsy factors in predicting unfavorable disease in patients eligible for active surveillance according to the PRIAS criteria.

Russo GI, Castelli T, Favilla V, Reale G, Urzì D, Privitera S, Fragalà E, Cimino S, Morgia G.

Prostate Cancer Prostatic Dis. 2015 Dec;18(4):338-42. doi: 10.1038/pcan.2015.26. Epub 2015 Jun 2.

PMID:
26032650
18.

Increase of Framingham cardiovascular disease risk score is associated with severity of lower urinary tract symptoms.

Russo GI, Castelli T, Privitera S, Fragalà E, Favilla V, Reale G, Urzì D, La Vignera S, Condorelli RA, Calogero AE, Cimino S, Morgia G.

BJU Int. 2015 Nov;116(5):791-6. doi: 10.1111/bju.13053. Epub 2015 Mar 25.

19.

Relationship between urodynamic findings and sexual function in multiple sclerosis patients with lower urinary tract dysfunction.

Fragalà E, Russo GI, Di Rosa A, Giardina R, Privitera S, Favilla V, Castelli T, Chisari M, Caramma A, Patti F, Cimino S, Morgia G.

Eur J Neurol. 2015 Mar;22(3):485-92. doi: 10.1111/ene.12595. Epub 2014 Nov 19.

PMID:
25410608
20.

Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study.

Russo GI, Cimino S, Fragalà E, Privitera S, La Vignera S, Condorelli R, Calogero AE, Chisari M, Castelli T, Favilla V, Morgia G.

World J Urol. 2015 May;33(5):743-51. doi: 10.1007/s00345-014-1392-4. Epub 2014 Sep 5.

PMID:
25189458

Supplemental Content

Loading ...
Support Center